Wolverine Trading, LLC Ironwood Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $438,464 - $814,215	52,700 New	52,700 $459,000
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $168,699 - $204,792	-15,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $22,806 - $29,295	2,100 Added 15.22%	15,900 $186,000
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $34,568 - $40,368	2,900 Added 26.61%	13,800 $183,000
Q2 2021 Aug 06, 2021	SELL	$10.16 - $13.11 $85,344 - $110,124	-8,400 Reduced 43.52%	10,900 $139,000
Q3 2018 Nov 14, 2018	SELL	$14.31 - $17.65 $18,603 - $22,944	-1,300 Reduced 6.31%	19,300 $356,000
Q1 2018 May 15, 2018	BUY	$11.13 - $13.63 $32,277 - $39,527	2,900 Added 16.38%	20,600 $318,000
Q3 2017 Nov 15, 2017	BUY	$12.07 - $14.87 $213,639 - $263,199	17,700	17,700 $279,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.